Learning Objectives:
1. Understand the rationale for using immune checkpoint blockade as a tool for preventing progression to oral cancer.
2. Appreciate the evolving impact of plasma HPV ctDNA on diagnosis, surveillance, and as a potential biomarker across the HPV cancer spectrum
3. Understand how immune effector cell therapies are being applied to solid tumors (not just hematologic malignancies)
Session date:
01/24/2022 - 12:00pm to 1:00pm CST
Location:
Virtually
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Glenn Hanna, MD